View our top six events to look out for this week (13-17 March), plus our key company earnings schedule.
Will the expected Fed rate rise be the first of many?
Wednesday has the potential to be a big turning point for US markets. While the Federal Reserve is widely expected to raise interest rates, traders may look for hints as to how many more increases are planned, and what impact the end of the debt ceiling deal could have on government and monetary policy.
Watch the video preview >
Can Prudential protect its share price?
Tuesday: Prudential is expected to report adjusted earnings per share of £1.14 in its full-year results, down 9% from a year ago. Focus may be on the M&G asset management division in light of its first-half disappointment and the recent merger announcement between Standard Life and Aberdeen Asset Management.
Bank of England, Brexit and jobs data
Wednesday-Thursday: It’s a big week for the UK, with unemployment figures on Wednesday and the Bank of England meeting on Thursday. The impact of a lower pound on inflation remains in focus, along with the Brexit debate, which shifts back to the House of Commons amid rumours that Theresa May could trigger Article 50 as soon as Wednesday.
How will the Netherlands election impact the euro?
Wednesday: The first in a series of key eurozone elections this year, the Netherlands election will be the first test of strength for Eurosceptic parties. A strong showing could undermine confidence in the euro and raise the risk of a break up, while a poor performance could embolden pro-eurozone believers and boost the euro.
Oracle quarterly earnings due
Wednesday: Sales for the database software company are expected to grow slightly to $9.25bn after last quarter’s $9bn came in slightly below expectations. Oracle's shift in focus from legacy products to cloud computing could attract attention from analysts and traders.
US debt ceiling agreement expires; Trump Budget proposal
Wednesday-Thursday: This is the week the rubber starts to hit the road in the US. Stocks have soared on speculation President Trump may bring in pro-business policies to boost corporate earnings. His first Budget proposal on Thursday may indicate which areas he plans to focus on this year – any areas that had rallied strongly but miss out on funding this year could be particularly vulnerable.
Index dividend schedule
If you trade indices, dividend payments from an index's constituent shares can result in either a credit or debit to your account. View this week's indices dividend drop points table.
Selected UK & US company earnings schedule
|Monday 13 March||Results|
|Aratana Therapeutics (US)||Q4|
|Argonaut Gold (US)||Q4|
|Atlas Financial Holdings (US)||Q4|
|Bellicum Pharmaceuticals (US)||Q4|
|Coherus Biosciences (US)||Q4|
|Green Brick Partners (US)||Q4|
|GSV Capital (US)||Q4|
|H&T Group (UK)||Full-year|
|Inter Parfums (US)||Q4|
|Investors Real Estate Trust (US)||Q3|
|KMG Chemicals (US)||Q2|
|Lifetime Brands (US)||Q4|
|Peregrine Pharmaceuticals (US)||Q3|
|Resource Capital (US)||Q4|
|Telit Communications (UK)||Full-year|
|Tuesday 14 March||Results|
|Advanced Medical Solutions Group (UK)||Full-year|
|Antares Pharma (US)||Q4|
|Arena Pharmaceuticals (US)||Q4|
|Celldex Therapeutics (US)||Q4|
|Cobalt International Energy (US)||Q4|
|Everi Holdings (US)||Q4|
|Hawaiian Telcom Holdco (US)||Q4|
|HD Supply (US)||Q4|
|Infinity Pharmaceuticals (US)||Q4|
|NexPoint Residential Trust (US)||Q4|
|Nexteer Automotive (US)||Full-year|
|Pantheon International (UK)||Q2|
|PTC Therapeutics (US)||Q4|
|Rosetta Stone (US)||Q4|
|TP ICAP (UK)||Full-year|
|Wednesday 15 March||Results|
|Abraxas Petroleum (US)||Q4|
|Avid Technology (US)||Q4|
|Brooks Macdonald Group (UK)||Half-year|
|Christopher & Banks (US)||Q4|
|Clinigen Group (UK)||Half-year|
|Contango Oil & Gas (US)||Q4|
|Gem Diamonds (UK)||Q4|
|Heritage Insurance Holdings (US)||Q4|
|Jabil Circuit (US)||Q2|
|Miller Industries (US)||Q4|
|Ring Energy (US)||Q4|
|Robert Walters (UK)||Full-year|
|Titan International (US)||Q4|
|Thursday 16 March||Results|
|Adobe Systems (US)||Q1|
|Balfour Beatty (UK)||Full-year|
|EMIS Group (UK)||Full-year|
|Insys Therapeutics (US)||Q4|
|M&C Saatchi (UK)||Full-year|
|OneSavings Bank (UK)||Full-year|
|Range Resources (UK)||Half-year|
|Samsonite International SA (US)||Full-year|
|Tiffany & Co (US)||Q4|
|US Physical Therapy (US)||Q4|
|Friday 17 March||Results|
|Vivint Solar (US)||Q4|
Company announcements are subject to change. All the events listed above were correct at the time of writing.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
Disclaimer: CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.